SCHEMBL3463347

SCHEMBL3463347

COc1cc(C)ccc1S(=O)(=O)N1CCc2c(n[nH]c2-c2nc3cc(C)c(C)cc3[nH]2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN3 Q8TDD5 1/20 0.44
AMY1A P0DUB6 5/20 0.39
ALDH1A1 P00352 4/20 0.38
POLB P06746 2/20 0.38
GAA P10253 2/20 0.37
USP2 O75604 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
ERAP1 Q9NZ08 1/20 0.36
MAPT P10636 4/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
PKM P14618 1/20 0.35
CYP1A1 P04798 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3458954 0.85 CD4 (0.43) ALDH1A1NPC1RAB9AATMERAP1
SCHEMBL14031947 0.85 NPC1 (0.40) AMY1AALDH1A1POLBGAAKMT2A
SCHEMBL3455927 0.83 PKM (0.43) AMY1AALDH1A1GAAUSP2KMT2A
SCHEMBL3457131 0.83 GRM5 (0.38) ALDH1A1POLBGAAUSP2KMT2A
SCHEMBL3459484 0.82 NPC1 (0.39) AMY1APOLBKMT2ANPC1RAB9A
SCHEMBL3455987 0.82 MAPT (0.46) AMY1AALDH1A1POLBGAAUSP2
SCHEMBL3458009 0.82 NPC1 (0.39) ALDH1A1GAAUSP2KMT2ANPC1
SCHEMBL3455272 0.81 HTR6 (0.43) AMY1AALDH1A1POLBKMT2ANPC1
SCHEMBL3455109 0.81 NPC1 (0.40) AMY1AALDH1A1KMT2ANPC1RAB9A
SCHEMBL3456017 0.80 ALPL (0.42) GAAKMT2ANPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2251340-A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof Aventis Pharma S.A. (FR) 2010-11-17 EP disclosed